Comparison between Invicta Diagnostic IPO and Simca Advertising IPO.
Invicta Diagnostic IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Simca Advertising IPO is a SME Bookbuilding proposed to list at NSE SME.
| Invicta Diagnostic IPO | Simca Advertising IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Socradamus Capital Pvt.Ltd. | Socradamus Capital Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Nikunj Stock Brokers Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Invicta Diagnostic IPO is up to ₹26.71 Cr whereas the issue size of the Simca Advertising IPO is up to ₹0.00 Cr. The final issue price of Invicta Diagnostic IPO is ₹85.00 per share and of Simca Advertising IPO is .
| Invicta Diagnostic IPO | Simca Advertising IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹80.00 per share | |
| Issue Price (Upper) | ₹85.00 per share | |
| Issue Price (Final) | ₹85.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | |
| Fresh Issue Size | 31,42,400 shares | 31,72,000 shares |
| Fresh Issue Size (Amount) | up to ₹26.71 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 31,42,400 shares | 31,72,000 shares |
| Issue Size Total (Amount) | up to ₹26.71 Cr | up to ₹0.00 Cr |
Invicta Diagnostic IPO opens on Dec 01, 2025, while Simca Advertising IPO opens on . The closing date of Invicta Diagnostic IPO and Simca Advertising IPO is Dec 03, 2025, and , respectively.
| Invicta Diagnostic IPO | Simca Advertising IPO | |
|---|---|---|
| Anchor Bid Date | Nov 28, 2025 | |
| Issue Open | Dec 01, 2025 | |
| Issue Close | Dec 03, 2025 | |
| Basis Of Allotment (Tentative) | Dec 04, 2025 | |
| Initiation of Refunds (Tentative) | Dec 05, 2025 | |
| Credit of Share (Tentative) | Dec 05, 2025 | |
| Listing date (Tentative) | Dec 08, 2025 | |
| Anchor Lockin End date 1 | Jan 02, 2026 | |
| Anchor Lockin End date 2 | Mar 03, 2026 |
Invicta Diagnostic IPO P/E ratio is 14.51, as compared to Simca Advertising IPO P/E ratio of .
| Invicta Diagnostic IPO | Simca Advertising IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Invicta Diagnostic Ltd.'s revenue increased by 90% and profit after tax (PAT) rose by 30% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Simca Advertising Ltd.'s revenue increased by 52% and profit after tax (PAT) rose by 73% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 90.52 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.69 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.51 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹106.86 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 44.28% | 57.44% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 42.00% | 76.57% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 36.25% | 57.44% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Invicta Diagnostic IPO Retail Individual Investors (RII) are offered 12,67,200 shares while in Simca Advertising IPO retail investors are offered 12,67,200 shares. Qualified Institutional Buyers (QIB) are offered 5,34,400 shares in Invicta Diagnostic IPO and 0 shares in Simca Advertising IPO.
| Invicta Diagnostic IPO | Simca Advertising IPO | |
|---|---|---|
| Anchor Investor Reservation | 7,98,400 shares | 0 shares |
| Market Maker Reservation | 1,66,400 shares | 0 shares |
| QIB | 5,34,400 shares | 0 shares |
| NII | 5,42,400 shares | 0 shares |
| RII | 12,67,200 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 31,42,400 shares | 0 shares |
Invicta Diagnostic IPO subscribed 4.27x in total, whereas Simca Advertising IPO subscribed .
| Invicta Diagnostic IPO | Simca Advertising IPO | |
|---|---|---|
| QIB (times) | 3.51x | |
| NII (times) | 6.96x | |
| Big NII (times) | 7.30x | |
| Small NII (times) | 6.27x | |
| RII (times) | 3.44x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 4.27x |
